肛门镜下注射聚桂醇治疗出血性内痔临床观察.docVIP

肛门镜下注射聚桂醇治疗出血性内痔临床观察 　　【摘要】 目的 探讨肛门镜下注射聚桂醇对出血性内痔的临床疗效 。方法 出血性内痔患者248例， 随机分为治疗组（采用聚桂醇注射）126例， 对照组（采用消痔灵注射）122例；观察患者术后的症状与体征变化， 并记录术后的并发症及随访结果。结果 两组术后止血有效率均达到100.0%， 但术后肛门内胀痛、肛缘水肿、尿潴留、术后2～6个月便血复发及肛门内硬结伴排便困难等并发症比较， 差异有统计学意义（P0.05）。结论 肛门镜下聚桂醇注射治疗出血性内痔优于消痔灵注射， 具有疗效确切、操作简便、并发症少等优点， 值得临床推广。 　　【关键词】 聚桂醇；注射；出血性内痔 　　DOI：10.14163/j.cnki.11-5547/r.2015.11.013 　　Clinical observation of lauromacrogol through anoscopic injection in the treatment of hemorrhagic internal hemorrhoids LIANG Qi-shou， LIU Cheng-wei. Department of Anorectum， Guangdong Shaoguan City Yuebei People’s Hospital， Shaoguan 512026， China 　　【Abstract】 Objective To investigate the clinical effect of lauromacrogol through anoscopic injection in the treatment of hemorrhagic internal hemorrhoids. Methods A total of 248 patients of hemorrhagic internal hemorrhoids were randomly divided into treatment group （lauromacrogol injection） with 126 cases and control group （Xiaozhiling injection） with 122 cases. Changes of symptoms and signs were observed after operation， and records were made on postoperative complications and follow-up outcomes. Results The hemostasis effective rates of the two group were all 100.0%， while there were still statistically significant differences of complications as postoperative anal pain， edema， uroschesis， and hemafecia relapse and scleroma scar with difficult defecation in 2～6 months of follow-up between the two groups （P0.05）. Conclusion Lauromacrogol through anoscopic injection in the treatment of hemorrhagic internal hemorrhoids has better effect than Xiaozhiling injection. It has the advantages of precise effect， easy operation， and few complications. This method is worthy of clinical promotion. 　　【Key words】 Lauromacrogol； Injection； Hemorrhagic internal hemorrhoids 　　出血性内痔是肛肠疾病最为常见且较为严重的一种类型， 反复地大便带血、便后滴血甚至喷射状出血给患者的健康带来很大的危害。本科在2013年7月～2014年6月采用肛门镜下注射聚桂醇治疗出血性内痔患者126例， 取得满意疗效， 现报告如下。 　　1 资料与方法 　　1. 1 一般资料 按照1994年国家中医管理局制订的《中医病证诊断疗效标准》[1]， 将本院在上述时间内收治的明确诊断为（Ⅰ、Ⅱ、Ⅲ期）出血性内痔患者248例，